1573 Amisulpride, a dopamine D2/D3-antagonist, prevents chemotherapyinduced nausea and vomiting (CINV) in patients receiving highly emetogenic cisplatin or anthracycline-cyclophosphamide regimens: A randomised, double-blind, placebo-controlled, dose-ranging trial. (September 2015) - Herrstedt, J.; Summers, Y.; Jordan, K.; Von Pawel, J.; Jakobsen, A.H.; Ewertz, M.; Chan, S.; Naik, J.; Karthaus, M.; Dubey, S.; Davis, R.; Fox, G.